weight regain after tirzepatide Rebound gain stopping semaglutide or is real, but it's not because the body is “damaged”—it reflects how the body adapts after weight loss. When the medication is stopped, hunger New research providing further support

Results Over a median follow-up of four years, the primary composite outcome occurred in 12.2 percent of the tirzepatide group and 13.1 percent of the dulaglutide group

Side effect profiles for compounded semaglutide match those of brand-name formulations, including nausea, constipation, and appetite suppression that typically improve within 2 to 3 weeks as the body adapts

Research mechanism GLP-1 receptor activation in pancreatic -cells, hypothalamus, brainstem Glucose-dependent insulin secretion Delayed gastric emptying Central appetite suppression via hypothalamic and brainstem receptors Trial data summary STEP 1 trial (Wilding et al., NEJM 2021): mean body weight reduction of 14.9% at 68 weeks with weekly 2.4mg dosing

Providers usually recommend waiting at least 612 weeks postpartum, allowing time for healing and stabilization

1B and S1)

doi: 10.3390/nu11051136